Gufic Biosciences Limited (NSE:GUFICBIO)
India · Delayed Price · Currency is INR 431.70
-5.75 (-1.31%)
Sep 24, 2026, 12:55 PM IST
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 43.81 billion as of September 23, 2026. Its market cap has increased by 17.53% in one year.
Market Cap
43.81B
Enterprise Value
47.24B
Revenue
9.81B
Ranking
n/a
PE Ratio
59.64
Stock Price
431.70
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 43.81B, an increase of 12,168.00%. That is a compound annual growth rate of 20.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 43.81B | 29.74% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 76.74B |
| Innova Captab | 68.57B |
| Sun Pharma Advanced Research Company | 63.64B |
| Orchid Pharma | 50.20B |
| RPG Life Sciences | 46.35B |
| Solara Active Pharma Sciences | 36.34B |
| Ind-Swift Laboratories | 32.46B |
| Sakar Healthcare | 26.25B |